MyoKardia

MyoKardia

World Rank (Aug-2026)
3600
World Rank (Jan-05-2024)
3,600
World Rank (Jul-30-2023)
3,600
World Rank (Jan-07-2022)
3,600
World Rank (Jan-01-2021)
3,600
Headquarters Country
USA
Top Healthcare Companies in USA
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
0 Million USD
Annual Operating Income in USD
-288 Million USD
Annual Net Income in USD
-276 Million USD
Annual Results for Period Ending
For year ending December-2019
Total Assets in USD
456 Million USD
Total Liabilities in USD
50 Million USD
Total Equity in USD
406 Million USD
Balance Sheet for Period Ending
As of December-2019
Business Sector
Healthcare
HealthCare Products
Biotechnology
Company Website
MYOKARDIA INC
Company Profile

MyoKardia is a Transformative Therapies company. It is applying a precision medicine approach to develop therapeutic candidates for patient populations with shared characteristics such as causal genetic mutations or disease subtypes. The headquarters is in USA.

Bristol Myers Squibb acquired MyoKardia for 13.1 Billion USD in Nov-2020.

 

Facts About Company

Bristol Myers Squibb acquired MyoKardia for 13.1 Billion USD in Nov-2020

IPO Year
2015
Stock Exchange
Nasdaq
Frankfurt

Share